1 |
Castilho, A., Neumann, L., Daskalova, S., Mason, H. S., Steinkellner, H., Altmann, F., and Strasser, R. (2012). Engineering of sialylated mucin-type O-glycosylation in plants. J. Biol. Chem. 287, 36518-36526.
DOI
|
2 |
Cazzola, M., Mercuriali, F., and Brugnara, C. (1997). Use of recombinant human erythropoietin outside the setting of uremia. Blood 89, 4248-4267.
|
3 |
Council of Europe. (2007). European Pharmacopoeia, 6th eds. (Strasbourg, France: Council of Europe).
|
4 |
Davis, J.M., Arakawa, T., Strickland, T.W., and Yphantis, D.A. (1987). Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells. Biochemistry 26, 2633-2638.
DOI
ScienceOn
|
5 |
Delorme, E., Lorenzini, T., Giffin, J., Martin, F., Jacobsen, F., Boone, T., and Elliott, S. (1992). Role of glycosylation on the secretion and biological activity of erythropoietin. Biochemistry 31, 9871-9876.
DOI
ScienceOn
|
6 |
Dudkiewicz-Wilczynska, J., Snycerski, A., and Tautt, J. (2002). Application of high-performance size exclusion chromatography to the determination of erythropoietin in pharmaceutical preparations. Acta pol. Pharm. 59, 83-86.
|
7 |
Elliott, S., Egrie, J., Browne, J., Lorenzini, T., Busse, L., Rogers, N., and Ponting, I. (2004). Control of rHuEPO biological activity: the role of carbohydrate. Exp. Hematol. 32, 1146-1155.
DOI
ScienceOn
|
8 |
Fukuda, M.N., Sasaki, H., Lopez, L., and Fukuda, M. (1989). Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 73, 84-89.
|
9 |
Gimenez, E., Ramos-Hernan, R., Benavente, F., Barbosa, J., and Sanz-Nebot, V. (2012). Analysis of recombinant human erythropoietin glycopeptides by capillary electrophoresis electrospray- time of flight-mass spectrometry. Anal. Chim. acta 709, 81-90.
DOI
ScienceOn
|
10 |
Goldwasser, E., and Kung, C.K. (1968). Progress in the purification of erythropoietin. Ann. N Y Acad. Sci. 149, 49-53.
DOI
|
11 |
Gong, B., Burnina, I., Stadheim, T.A., and Li, H. (2013) Glycosylation characterization of recombinant human erythropoietin produced in glycoengineered Pichia pastoris by mass spectrometry. J. Mass Spectrom. 48, 1308-1317.
DOI
ScienceOn
|
12 |
Hokke, C.H., Bergwerff, A.A., Dedem, G.W., Kamerling, J.P., and Vliegenthart, J.F. (1995). Structural analysis of the sialylated N-and O-linked carbohydrate chains of recombinant human erythropoietin expressed in chinese hamster ovary cells. Eur. J. Biochem. 228, 981-1008.
DOI
|
13 |
Kolarich, D., Jensen, P.H., Altmann, F., and Packer, N.H. (2012). Determination of site-specific glycan heterogeneity on glycoproteins. Nat. Protoc. 7, 1285-1298.
DOI
ScienceOn
|
14 |
Llop, E., Gutierrez-Gallego, R., Segura, J., Mallorqui, J., and Pascual, J.A. (2008). Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo). Anal. Biochem. 383, 243-254.
DOI
ScienceOn
|
15 |
Rane, S.S., Ajameri, A., Mody, R., and Padmaja, P. (2012). Development and validation of RP-HPLC and RP-UPLC methods for quantification of erythropoietin formulated with human serum albumin. J. Pharm. Anal. 2, 160-165.
DOI
ScienceOn
|
16 |
Spivak, J.L. (1998). The biology and clinical applications of recombinant erythropoietin. Semin. Oncol. 25, 7-11.
|
17 |
Sasaki, H., Bothner, B., Dell, A., and Fukuda, M. (1987). Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J. Biol. Chem. 262, 12059-12076.
|
18 |
Sasaki, H., Ochi, N., Dell, A., and Fukuda, M. (1988). Site-specific glycosylation of human recombinant erythropoietin: analysis of glycopeptides or peptides at each glycosylation site by fast atom bombardment-mass spectrometry. Biochemistry 27, 8618- 8626.
DOI
ScienceOn
|
19 |
Song, K.E., Byeon, J., Moon, D.B., Kim, H.H., Choi, Y.J., and Suh, J.K.(2014) Structural identification of modified amino acids on the interface between EPO and its receptor from EPO BRP, human recombinant erythropoietin by LC/MS analysis. Mol. Cells 37, 819-826.
DOI
ScienceOn
|
20 |
Spivak, J.L., and Hogans, B.B. (1989). The in vivo metabolism of recombinant human erythropoietin in the rat. Blood 73, 90-99.
|
21 |
Stubiger, G., Marchetti, M., Nagano, M., Grimm, R., Gmeiner, G., Reichel, C., and Allmaier, G. (2005). Characterization of N-and O-glycopeptides of recombinant human erythropoietins as potential biomarkers for doping analysis by means of microscale sample purification combined with MALDI-TOF and quadrupole IT/RTOF mass spectrometry. J. Cell. Sci. 28, 1764-1778.
|
22 |
Sytkowski A.J. (2004). Erythropoietin: blood, brain and beyond (Weinheim, Germany: Wiley-VCH Verlag).
|
23 |
Toyoda, T., Itai, T., Arakawa, T., Aoki, K.H., and Yamaguchi, H. (2000). Stabilization of human recombinant erythropoietin through interactions with the highly branched N-glycans. J. Biochem. 128, 731-737.
DOI
ScienceOn
|
24 |
Wilczynska, J.D., Roman, I., and Anuszewska, E. (2005). The separation of EPO from other proteins in medical products formulated with different stabilizers. Acta Pol. Pharm. 62, 177-182.
|
25 |
Tsuda, E., Kawanishi, G., Ueda, M., Masuda, S., and Sasaki, R. (1990). The role of carbohydrate in recombinant human erythropoietin. Eur. J. Biochem. 188, 405-411.
DOI
ScienceOn
|
26 |
Wasley, L.C., Timony, G., Murtha, P., Stoudemire, J., Dorner, A.J., Caro, J., Krieger, M., and Kaufman, R.J. (1991). The importance of N-and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood 77, 2624-2632.
|